Taysha Gene Therapies, Inc.

TSHA

Biological Products, (No Diagnostic Substances)(DE)CIK: 1806310

Revenue (Latest FY)

$15.5M

Net Income (Latest FY)

-$111.6M

Industry

Biological Products, (No Diagnostic Substances)

Recent Filings

Company Details

CIK1806310

Fiscal Year End1231

Category<br>Emerging growth company

StateDE

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)